Freeline Therapeutics, a company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases, announced the pricing of its initial public offering in the United States. Freeline Nasdaq IPO is UCL Technology Fund's 3rd IPO since its inception in 2016. 

Read more

Quantexa, AlbionVC portfolio company named among the 15 leading European AI start-ups by the Business Insider. Quantexa uses artificial intelligence and big data to help banks and other major institutions to detect fraud. To date the company has raised $23.3 million. 

Read more

Aridhia, an AlbionVC portfolio company has set up International Covid-19 Data Research Alliance and Workbench to unite leading life science, philanthropic and research organisations to respond to the global pandeminic. 

Read more

Discover how AlbionVC and UCL Technology Fund portfolio companies within the AI space are responding to the pandemic. 

Read more

Epsilogen Ltd (formerly known as IGEM Therapeutics) announces it has closed a £3m A2 financing round from existing investors UCL Technology Fund, Epidarex Capital and Alsa Holdings.

Read more

Credit Kudos, a UK fintech using open banking to provide more accurate credit scoring, has raised £5 million in Series A funding led by AlbionVC

Read more

Locum's Nest technology connects short-staffed hospital departments and GP practices with thousands of clinicians a service they have made free to access in response to the Covid-19 virus

Read more

AstronauTx Ltd is a biotech company developing new medicines for the treatment of Alzheimer’s disease and other neurodegenerative diseases, announces £1 million investment from the UCL Technology Fund.

Read more